LEADER 00891cam2 2200265 450 001 E600200057778 005 20211027072732.0 010 $a8802046212 100 $a20091215d1994 |||||ita|0103 ba 101 $aita 102 $aIT 200 1 $a<<8.1: Il >>Piemonte sabaudo$estato e territori in età moderna$fPierpaolo Merlin ... [et al.] 210 $aTorino$cUTET$dc1994 215 $aXVI, 932 p.$cill.$d24 cm 461 1$1001E600200057752$12000 $aStoria d'Italia 702 1$aMerlin, Pierpaolo$3A600200058874$4070 801 0$aIT$bUNISOB$c20211027$gRICA 850 $aUNISOB 852 $aUNISOB$j900|Sto$m92083 912 $aE600200057778 940 $aM 102 Monografia moderna SBN 941 $aM 957 $a900|Sto$b000009$i-8.1$gNo$d92083$racquisto$1catenacci$2UNISOB$3UNISOB$420091215110733.0$520211027071424.0$6rovito 996 $aPiemonte sabaudo$9629518 997 $aUNISOB LEADER 01027nas 2200373 c 450 001 996211083303316 005 20180220201921.0 035 $a(CKB)1000000000529752 035 $a(DE-599)ZDB2255163-3 035 $a(OCoLC)166033714 035 $a(OCoLC)644388648 035 $a(DE-101)981593526 035 $a(EXLCZ)991000000000529752 100 $a20061019a20069999 |y | 101 0 $ager 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aVolkswirtschaft$h[...]$iWa?hrungen$fDekaBank 210 31$aFrankfurt, Main$aBerlin$cBank$d2006- 215 $aOnline-Ressource 300 $aGesehen am 17. Februar 2016 517 1 $aVolkswirtschaft / Wa?hrungen 608 $aZeitschrift$2gnd-content 676 $a330 712 02$aDekaBank Deutsche Girozentrale$4isb 801 0$b8999 801 1$bDE-101 801 2$b9999 906 $aJOURNAL 912 $a996211083303316 996 $aVolkswirtschaft$9185113 997 $aUNISA LEADER 04634nam 2200577 450 001 9910828682803321 005 20230808192303.0 010 $a3-527-69931-7 010 $a3-527-69930-9 035 $a(CKB)3710000000621698 035 $a(EBL)4454425 035 $a(OCoLC)945445030 035 $a(MiAaPQ)EBC4454425 035 $a(Au-PeEL)EBL4454425 035 $a(CaPaEBR)ebr11175917 035 $a(CaONFJC)MIL909483 035 $a(EXLCZ)993710000000621698 100 $a20160413h20162016 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aCalcium orthophosphate-based bioceramics and biocomposites /$fSergey V. Dorozhkin 210 1$aWeinheim, Germany :$cWiley-VCH Verlag GmbH & Co.,$d2016. 210 4$d©2016 215 $a1 online resource (504 p.) 300 $aDescription based upon print version of record. 311 $a3-527-33788-1 320 $aIncludes bibliographical references and index. 327 $aRelated Titles; Title Page; Copyright; Table of Contents; Preface; Part I: Calcium Orthophosphates (CaPO4): Occurrence, Properties, and Biomimetics; Chapter 1: Introduction; References; Chapter 2: Geological and Biological Occurrences; References; Chapter 3: The Members of CaPO4 Family; 3.1 MCPM; 3.2 MCPA (or MCP); 3.3 DCPD; 3.4 DCPA (or DCP); 3.5 OCP; 3.6 ?-TCP; 3.7 ?-TCP; 3.8 ACP; 3.9 CDHA (or Ca-def HA, or CDHAp); 3.10 HA (or HAp, or OHAp); 3.11 FA (or FAp); 3.12 OA (or OAp, or OXA); 3.13 TTCP (or TetCP); 3.14 Biphasic, Triphasic, and Multiphasic CaPO4 Formulations 327 $a3.15 Ion-Substituted CaPO4References; Chapter 4: Biological Hard Tissues of CaPO4; 4.1 Bone; 4.2 Teeth; 4.3 Antlers; References; Chapter 5: Pathological Calcification of CaPO4; References; Chapter 6: Biomimetic Crystallization of CaPO4; References; Chapter 7: Conclusions and Outlook; References; Part II: Calcium Orthophosphate Bioceramics in Medicine; Chapter 8: Introduction; References; Chapter 9: General Knowledge and Definitions; References; Chapter 10: Bioceramics of CaPO4; 10.1 History; 10.2 Chemical Composition and Preparation; 10.3 Forming and Shaping; 10.4 Sintering and Firing 327 $aReferencesChapter 11: The Major Properties; 11.1 Mechanical Properties; 11.2 Electric/Dielectric and Piezoelectric Properties; 11.3 Possible Transparency; 11.4 Porosity; References; Chapter 12: Biomedical Applications; 12.1 Self-Setting (Self-Hardening) Formulations; 12.2 Coatings, Films, and Layers; 12.3 Functionally Graded Bioceramics; References; Chapter 13: Biological Properties and In Vivo Behavior; 13.1 Interactions with Surrounding Tissues and the Host Responses; 13.2 Osteoinduction; 13.3 Biodegradation; 13.4 Bioactivity; 13.5 Cellular Response; References 327 $aChapter 14: Nonbiomedical Applications of CaPO4References; Chapter 15: CaPO4 Bioceramics in Tissue Engineering; 15.1 Tissue Engineering; 15.2 Scaffolds and Their Properties; 15.3 Bioceramic Scaffolds from CaPO4; 15.4 A Clinical Experience; References; Chapter 16: Conclusions and Outlook; References; Part III: Biocomposites from Calcium Orthophosphates; Chapter 17: Introduction; References; Chapter 18: General Information and Knowledge; References; Chapter 19: The Major Constituents of Biocomposites and Hybrid Biomaterials for Bone Grafting; 19.1 CaPO4; 19.2 Polymers 327 $a19.3 Inorganic Materials and CompoundsReferences; Chapter 20: Biocomposites and Hybrid Biomaterials Based on CaPO4; 20.1 Biocomposites with Polymers; 20.2 Self-Setting Formulations; 20.3 Formulations Based on Nanodimensional CaPO4 and Nanodimensional Biocomposites; 20.4 Biocomposites with Collagen; 20.5 Formulations with Other Bioorganic Compounds and/or Biological Macromolecules; 20.6 Injectable Bone Substitutes (IBSs); 20.7 Biocomposites with Glasses, Inorganic Compounds, Carbon, and Metals; 20.8 Functionally Graded Formulations; 20.9 Biosensors; References 327 $aChapter 21: Interaction among the Phases in CaPO4-Based Formulations 606 $aBiomedical materials$xTesting 606 $aBiomedical materials$xResearch 606 $aCalcium phosphate$xBiotechnology 615 0$aBiomedical materials$xTesting. 615 0$aBiomedical materials$xResearch. 615 0$aCalcium phosphate$xBiotechnology. 676 $a610.289 700 $aDorozhkin$b Sergey V.$0905288 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910828682803321 996 $aCalcium orthophosphate-based bioceramics and biocomposites$93976234 997 $aUNINA